Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.

First published in Cancer Chemotherapy and Pharmacology on 2014 Aug.
Cancer Chemother Pharmacol. 2014 Aug;74(2):267-75. doi: 10.1007/s00280-014-2484-y. Epub 2014 Jun 7.

Authors: Schnell D, Buschke S, Fuchs H, Gansser D, Goeldner RG, Uttenreuther-Fischer M, Stopfer P, Wind S, Petersen-Sylla M, Halabi A, Koenen R.

 

 

 

 

Read more

Download full article as Pdf file:

Pdf File

 

REACHING OUT IS EASY AND FAST – LET’S TALK

Martin Mulder

Senior Vice President Corporate & Business Development


LET’S TALK BUSINESS